Cargando…
Effects of Passage Number and Differentiation Protocol on the Generation of Dopaminergic Neurons from Rat Bone Marrow-Derived Mesenchymal Stem Cells
Multiple studies have demonstrated the ability of mesenchymal stem cells (MSCs) to differentiate into dopamine-producing cells, in vitro and in vivo, indicating their potential to be used in the treatment of Parkinson’s disease (PD). However, there are discrepancies among studies regarding the optim...
Autores principales: | Shall, Gabrielle, Menosky, Megan, Decker, Sarah, Nethala, Priya, Welchko, Ryan, Leveque, Xavier, Lu, Ming, Sandstrom, Michael, Hochgeschwender, Ute, Rossignol, Julien, Dunbar, Gary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877581/ https://www.ncbi.nlm.nih.gov/pubmed/29498713 http://dx.doi.org/10.3390/ijms19030720 |
Ejemplares similares
-
Genetic Rat Models of Parkinson's Disease
por: Welchko, Ryan M., et al.
Publicado: (2012) -
Reductions in behavioral deficits and neuropathology in the R6/2 mouse model of Huntington’s disease following transplantation of bone-marrow-derived mesenchymal stem cells is dependent on passage number
por: Rossignol, Julien, et al.
Publicado: (2015) -
Silencing of the Mutant Huntingtin Gene through CRISPR-Cas9 Improves the
Mitochondrial Biomarkers in an In Vitro Model of Huntington’s Disease
por: Dunbar, Gary L., et al.
Publicado: (2019) -
Effects of Bone-Marrow–Derived MSC Transplantation on Functional Recovery in a Rat Model of Spinal Cord Injury: Comparisons of Transplant Locations and Cell Concentrations
por: Matyas, Jessica J., et al.
Publicado: (2017) -
Use of Genetically Altered Stem Cells for the Treatment of Huntington’s Disease
por: Crane, Andrew T., et al.
Publicado: (2014)